3-(4-Bromophenyl)-2,2-dimethylpropanoic acid, 95%, 2.5g

5-Methoxyquinolin-8-ol, 95.0%, 250mg

1,2-Bis(4-methoxyphenyl)-2-oxoethyl cyclohexylcarbamate, 98%, 5g

Ethyl 4-methyl-3-nitrobenzoate, 95.0%, 25g

Methyl 2-amino-5-cyclopropylthiophene-3-carboxylate, 98%, 1g

2-Methylquinolin-3-ol, 1g

GC-Kapillarsäule ROTI®Cap-35 MS, L 30 m, Ø-Innen 0,25 mm, Filmd. 0,25 µm, 1 Stück

2,7-Dibromo-9,9-didecylfluorene>98.0%(HPLC)(T)25g

Sodium (S)-6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide, 95.0%, 100g

ETHYL 2-(1-NAPHTHYL)ACETATE, 95.0%, 500g

3-(3-Bromophenyl)-2-hydroxypropanoic acid, 95%, 1g

4,4,5,5-Tetramethyl-2-(5-methylthiophen-2-yl)-1,3,2-dioxaborolane, 95.0%, 5g

(4-Phenylnaphthalen-1-yl)boronic acid, 95.0%, 100g